BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31848103)

  • 1. Risk-based breast cancer screening strategies in women.
    Harkness EF; Astley SM; Evans DG
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():3-17. PubMed ID: 31848103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalised screening: is this the way forward?
    Gilbert FJ; Selamoglu A
    Clin Radiol; 2018 Apr; 73(4):327-333. PubMed ID: 29273223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening.
    Lee JM; Partridge SC; Liao GJ; Hippe DS; Kim AE; Lee CI; Rahbar H; Scheel JR; Lehman CD
    Clin Imaging; 2019; 55():119-125. PubMed ID: 30807927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
    Monticciolo DL; Newell MS; Moy L; Niell B; Monsees B; Sickles EA
    J Am Coll Radiol; 2018 Mar; 15(3 Pt A):408-414. PubMed ID: 29371086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan.
    Uematsu T
    Breast Cancer; 2017 Jan; 24(1):26-31. PubMed ID: 27259342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Advanced Breast Imaging Modalities.
    Alzaghal AA; DiPiro PJ
    Curr Oncol Rep; 2018 May; 20(7):57. PubMed ID: 29845403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.
    Aase HS; Holen ÅS; Pedersen K; Houssami N; Haldorsen IS; Sebuødegård S; Hanestad B; Hofvind S
    Eur Radiol; 2019 Mar; 29(3):1175-1186. PubMed ID: 30159620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dense Breast Ultrasound Screening After Digital Mammography Versus After Digital Breast Tomosynthesis.
    Dibble EH; Singer TM; Jimoh N; Baird GL; Lourenco AP
    AJR Am J Roentgenol; 2019 Dec; 213(6):1397-1402. PubMed ID: 31553658
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer screening controversies: who, when, why, and how?
    Chetlen A; Mack J; Chan T
    Clin Imaging; 2016; 40(2):279-82. PubMed ID: 26093511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-based Breast Cancer Screening: Implications of Breast Density.
    Lee CI; Chen LE; Elmore JG
    Med Clin North Am; 2017 Jul; 101(4):725-741. PubMed ID: 28577623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.